目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Application
Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 06: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 07: Parent market
Exhibit 08: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 09: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 10: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 11: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 12: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 13: Chart on Japan: Year-over-year growth 2022-2027 (%)
Exhibit 14: Data Table on Japan: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Regenerative medicine market in Japan 2017 - 2021
Exhibit 15: Historic Market Size - Data Table on regenerative medicine market in Japan 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 16: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Technology Segment Analysis 2017 - 2021
Exhibit 17: Historic Market Size - Technology Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 25: Chart on Application - Market share 2022-2027 (%)
Exhibit 26: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 27: Chart on Comparison by Application
Exhibit 28: Data Table on Comparison by Application
6.3 Oncology - Market size and forecast 2022-2027
Exhibit 29: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 30: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 31: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 32: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 Musculoskeletal - Market size and forecast 2022-2027
Exhibit 33: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 34: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibit 36: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
6.5 Dermatology - Market size and forecast 2022-2027
Exhibit 37: Chart on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibit 38: Data Table on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Chart on Dermatology - Year-over-year growth 2022-2027 (%)
Exhibit 40: Data Table on Dermatology - Year-over-year growth 2022-2027 (%)
6.6 Immunology and Inflammation and others - Market size and forecast 2022-2027
Exhibit 41: Chart on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibit 42: Data Table on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Chart on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
Exhibit 44: Data Table on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 45: Market opportunity by Application ($ million)
Exhibit 46: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology
7.1 Market segments
Exhibit 47: Chart on Technology - Market share 2022-2027 (%)
Exhibit 48: Data Table on Technology - Market share 2022-2027 (%)
7.2 Comparison by Technology
Exhibit 49: Chart on Comparison by Technology
Exhibit 50: Data Table on Comparison by Technology
7.3 Cell and tissue-based - Market size and forecast 2022-2027
Exhibit 51: Chart on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
7.4 Gene therapy - Market size and forecast 2022-2027
Exhibit 55: Chart on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Technology
Exhibit 59: Market opportunity by Technology ($ million)
Exhibit 60: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 62: Impact of drivers and challenges in 2022 and 2027
9.4 Market trends

10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 63: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 64: Overview on factors of disruption
10.4 Industry risks
Exhibit 65: Impact of key risks on business

11 Vendor Analysis
11.1 Vendors covered
Exhibit 66: Vendors covered
11.2 Market positioning of vendors
Exhibit 67: Matrix on vendor position and classification
11.3 Astellas Pharma Inc.
Exhibit 68: Astellas Pharma Inc. - Overview
Exhibit 69: Astellas Pharma Inc. - Product / Service
Exhibit 70: Astellas Pharma Inc. - Key news
Exhibit 71: Astellas Pharma Inc. - Key offerings
11.4 Becton Dickinson and Co.
Exhibit 72: Becton Dickinson and Co. - Overview
Exhibit 73: Becton Dickinson and Co. - Business segments
Exhibit 74: Becton Dickinson and Co. - Key news
Exhibit 75: Becton Dickinson and Co. - Key offerings
Exhibit 76: Becton Dickinson and Co. - Segment focus
11.5 CellSeed Inc.
Exhibit 77: CellSeed Inc. - Overview
Exhibit 78: CellSeed Inc. - Product / Service
Exhibit 79: CellSeed Inc. - Key offerings
11.6 Cyfuse Biomedical K.K.
Exhibit 80: Cyfuse Biomedical K.K. - Overview
Exhibit 81: Cyfuse Biomedical K.K. - Product / Service
Exhibit 82: Cyfuse Biomedical K.K. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
Exhibit 83: F. Hoffmann La Roche Ltd. - Overview
Exhibit 84: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 85: F. Hoffmann La Roche Ltd. - Key news
Exhibit 86: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 87: F. Hoffmann La Roche Ltd. - Segment focus
11.8 FUJIFILM Corp.
Exhibit 88: FUJIFILM Corp. - Overview
Exhibit 89: FUJIFILM Corp. - Business segments
Exhibit 90: FUJIFILM Corp. - Key news
Exhibit 91: FUJIFILM Corp. - Key offerings
Exhibit 92: FUJIFILM Corp. - Segment focus
11.9 iHeart Japan Corp.
Exhibit 93: iHeart Japan Corp. - Overview
Exhibit 94: iHeart Japan Corp. - Product / Service
Exhibit 95: iHeart Japan Corp. - Key offerings
11.10 JCR Pharmaceticals Co. Ltd.
Exhibit 96: JCR Pharmaceticals Co. Ltd. - Overview
Exhibit 97: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibit 98: JCR Pharmaceticals Co. Ltd. - Key offerings
11.11 Nikon Corp.
Exhibit 99: Nikon Corp. - Overview
Exhibit 100: Nikon Corp. - Business segments
Exhibit 101: Nikon Corp. - Key news
Exhibit 102: Nikon Corp. - Key offerings
Exhibit 103: Nikon Corp. - Segment focus
11.12 ROHTO Pharmaceutical Co. Ltd.
Exhibit 104: ROHTO Pharmaceutical Co. Ltd. - Overview
Exhibit 105: ROHTO Pharmaceutical Co. Ltd. - Business segments
Exhibit 106: ROHTO Pharmaceutical Co. Ltd. - Key offerings
Exhibit 107: ROHTO Pharmaceutical Co. Ltd. - Segment focus
11.13 Sumitomo Pharma Co. Ltd.
Exhibit 108: Sumitomo Pharma Co. Ltd. - Overview
Exhibit 109: Sumitomo Pharma Co. Ltd. - Business segments
Exhibit 110: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibit 111: Sumitomo Pharma Co. Ltd. - Segment focus
11.14 Takara Bio Inc.
Exhibit 112: Takara Bio Inc. - Overview
Exhibit 113: Takara Bio Inc. - Product / Service
Exhibit 114: Takara Bio Inc. - Key offerings
11.15 Takeda Pharmaceutical Co. Ltd.
Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Key offerings
11.16 Terumo Corp.
Exhibit 119: Terumo Corp. - Overview
Exhibit 120: Terumo Corp. - Business segments
Exhibit 121: Terumo Corp. - Key news
Exhibit 122: Terumo Corp. - Key offerings
Exhibit 123: Terumo Corp. - Segment focus
11.17 Yokogawa Electric Corp.
Exhibit 124: Yokogawa Electric Corp. - Overview
Exhibit 125: Yokogawa Electric Corp. - Business segments
Exhibit 126: Yokogawa Electric Corp. - Key offerings
Exhibit 127: Yokogawa Electric Corp. - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 128: Inclusions checklist
Exhibit 129: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 130: Currency conversion rates for US$
12.4 Research methodology
Exhibit 131: Research methodology
Exhibit 132: Validation techniques employed for market sizing
Exhibit 133: Information sources
12.5 List of abbreviations
Exhibit 134: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
Exhibits6: Executive Summary - Chart on Vendor Market Positioning
Exhibits7: Parent market
Exhibits8: Market Characteristics
Exhibits9: Offerings of vendors included in the market definition
Exhibits10: Market segments
Exhibits11: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits12: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits13: Chart on Japan: Year-over-year growth 2022-2027 (%)
Exhibits14: Data Table on Japan: Year-over-year growth 2022-2027 (%)
Exhibits15: Historic Market Size - Data Table on regenerative medicine market in Japan 2017 - 2021 ($ million)
Exhibits16: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits17: Historic Market Size - Technology Segment 2017 - 2021 ($ million)
Exhibits18: Five forces analysis - Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition - Five forces 2022 and 2027
Exhibits25: Chart on Application - Market share 2022-2027 (%)
Exhibits26: Data Table on Application - Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by Application
Exhibits28: Data Table on Comparison by Application
Exhibits29: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits30: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits31: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibits34: Data Table on Musculoskeletal - Market size and forecast 2022-2027 ($ million)
Exhibits35: Chart on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Musculoskeletal - Year-over-year growth 2022-2027 (%)
Exhibits37: Chart on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibits38: Data Table on Dermatology - Market size and forecast 2022-2027 ($ million)
Exhibits39: Chart on Dermatology - Year-over-year growth 2022-2027 (%)
Exhibits40: Data Table on Dermatology - Year-over-year growth 2022-2027 (%)
Exhibits41: Chart on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibits42: Data Table on Immunology and Inflammation and others - Market size and forecast 2022-2027 ($ million)
Exhibits43: Chart on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
Exhibits44: Data Table on Immunology and Inflammation and others - Year-over-year growth 2022-2027 (%)
Exhibits45: Market opportunity by Application ($ million)
Exhibits46: Data Table on Market opportunity by Application ($ million)
Exhibits47: Chart on Technology - Market share 2022-2027 (%)
Exhibits48: Data Table on Technology - Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Technology
Exhibits50: Data Table on Comparison by Technology
Exhibits51: Chart on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Cell and tissue-based - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Cell and tissue-based - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Gene therapy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Gene therapy - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Technology ($ million)
Exhibits60: Data Table on Market opportunity by Technology ($ million)
Exhibits61: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits62: Impact of drivers and challenges in 2022 and 2027
Exhibits63: Overview on Criticality of inputs and Factors of differentiation
Exhibits64: Overview on factors of disruption
Exhibits65: Impact of key risks on business
Exhibits66: Vendors covered
Exhibits67: Matrix on vendor position and classification
Exhibits68: Astellas Pharma Inc. - Overview
Exhibits69: Astellas Pharma Inc. - Product / Service
Exhibits70: Astellas Pharma Inc. - Key news
Exhibits71: Astellas Pharma Inc. - Key offerings
Exhibits72: Becton Dickinson and Co. - Overview
Exhibits73: Becton Dickinson and Co. - Business segments
Exhibits74: Becton Dickinson and Co. - Key news
Exhibits75: Becton Dickinson and Co. - Key offerings
Exhibits76: Becton Dickinson and Co. - Segment focus
Exhibits77: CellSeed Inc. - Overview
Exhibits78: CellSeed Inc. - Product / Service
Exhibits79: CellSeed Inc. - Key offerings
Exhibits80: Cyfuse Biomedical K.K. - Overview
Exhibits81: Cyfuse Biomedical K.K. - Product / Service
Exhibits82: Cyfuse Biomedical K.K. - Key offerings
Exhibits83: F. Hoffmann La Roche Ltd. - Overview
Exhibits84: F. Hoffmann La Roche Ltd. - Business segments
Exhibits85: F. Hoffmann La Roche Ltd. - Key news
Exhibits86: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits87: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits88: FUJIFILM Corp. - Overview
Exhibits89: FUJIFILM Corp. - Business segments
Exhibits90: FUJIFILM Corp. - Key news
Exhibits91: FUJIFILM Corp. - Key offerings
Exhibits92: FUJIFILM Corp. - Segment focus
Exhibits93: iHeart Japan Corp. - Overview
Exhibits94: iHeart Japan Corp. - Product / Service
Exhibits95: iHeart Japan Corp. - Key offerings
Exhibits96: JCR Pharmaceticals Co. Ltd. - Overview
Exhibits97: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibits98: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibits99: Nikon Corp. - Overview
Exhibits100: Nikon Corp. - Business segments
Exhibits101: Nikon Corp. - Key news
Exhibits102: Nikon Corp. - Key offerings
Exhibits103: Nikon Corp. - Segment focus
Exhibits104: ROHTO Pharmaceutical Co. Ltd. - Overview
Exhibits105: ROHTO Pharmaceutical Co. Ltd. - Business segments
Exhibits106: ROHTO Pharmaceutical Co. Ltd. - Key offerings
Exhibits107: ROHTO Pharmaceutical Co. Ltd. - Segment focus
Exhibits108: Sumitomo Pharma Co. Ltd. - Overview
Exhibits109: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits110: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits111: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits112: Takara Bio Inc. - Overview
Exhibits113: Takara Bio Inc. - Product / Service
Exhibits114: Takara Bio Inc. - Key offerings
Exhibits115: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits116: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits119: Terumo Corp. - Overview
Exhibits120: Terumo Corp. - Business segments
Exhibits121: Terumo Corp. - Key news
Exhibits122: Terumo Corp. - Key offerings
Exhibits123: Terumo Corp. - Segment focus
Exhibits124: Yokogawa Electric Corp. - Overview
Exhibits125: Yokogawa Electric Corp. - Business segments
Exhibits126: Yokogawa Electric Corp. - Key offerings
Exhibits127: Yokogawa Electric Corp. - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations